复星医药：上半年净利润17.02亿元，同比增长38.96%。

Core Viewpoint - Fosun Pharma reported a net profit of 1.702 billion yuan for the first half of the year, representing a year-on-year increase of 38.96% [1] Financial Performance - The company's net profit reached 1.702 billion yuan in the first half of the year [1] - This reflects a significant growth of 38.96% compared to the same period last year [1]